Skip to main content
OpenTrials
Completed

NCT Number: NCT01939340

Prevalence of Cachexia in Patients Undergoing Chemotherapy

Cachexia and low nutritional intake are a common phenomena in cancer patients undergoing chemotherapy. The purpose of this study is to assess prevalence of cachexia and low nutritional intake and the impact on quality of life, fatigue and mortality in patients undergoing chemotherapy. Furthermore interactions between these parameters, tumor disease and chemotherapy, respectively.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Body Weight Body Weight Changes Cachexia Neoplasms Pathological Conditions, Signs and Symptoms Signs and Symptoms Thinness Weight Loss

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dept. of Gastroenterology, Infectiology and Rheumatology (including workspace nutrition medicine), Charité Universitätsmedizin Berlin

Berlin, State of Berlin, 10117, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients undergoing chemotherapy at least in the second cycle.
  • Patients who have signed a written Informed Consent.

Exclusion criteria

  • Patients with implanted pacemaker or defibrillator.

Treatment and study plan

Primary outcomes

  1. Nutritional intake

    Time frame: 1 day

    Nutritional intake will be assessed by 24h-recall, which will be analysed with regard to macronutritients

Secondary outcomes

  1. Cachexia

    Time frame: 1 day

    Cachexia will be evaluated using the patient-generated Subjective Global Assessment.

  2. Quality of life and fatigue

    Time frame: 1 day

    EORTC QLQ C-30 will be used to assess quality of life and additionally cancer-related fatigue will be evaluated using Brief Fatigue Inventory.

  3. Mortality

    Time frame: 6 months

    Mortality will be assesses via telephone or consultation of the local death register

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Registry information

Official study title

Prevalence and Impact of Cachexia in Cancer Patients Undergoing Chemotherapy

Important dates

Study start
2010
Primary completion
2012
Study completion
2013
First posted
Sep 11, 2013
Registry last updated
Sep 12, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.